CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
LongActNow focuses on creating a new technology for long-acting pharmaceutical formulations by manipulating the formation of active ingredients. This project aims to improve the stability and effectiveness of injectable medications, enhancing patient comfort and treatment efficiency.
LongActNow will design a novel platform technology for the development of long acting (LA) suspensions of complex active pharmaceutical ingredients (API), involving innovative manipulation of API crystal formation and growth and solvent removal. LA formulations have become a game-changer in terms of bringing existing and new API in more cost-efficient and comfortable ways to patients, often directly impacting commercial viability of new products.
However, existing technology platforms are only a…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Dortmund
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Belgium, Beerse
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
